Global Insulin Delivery Devices Market
Medical Equipment

Insulin Delivery Devices Industry Valued at $26.3 Billion by 2029 With CAGR of 8.2% | Size and Share Insights

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Insulin Delivery Devices Market From 2025 To 2029?

The market for insulin delivery devices has experienced significant growth in recent times. It is projected to expand from a size of $17.71 billion in 2024 to $19.22 billion in 2025, experiencing a compound annual growth rate (CAGR) of 8.5%. Contributing factors to the growth seen during the historical period include the convenience and user-friendliness of insulin delivery devices, advantageous reimbursement policies, a rising prevalence of obesity, a growing elderly population, and an increased uptake of insulin pumps.

What Is the Projected Market Size of the Insulin Delivery Devices Market?

The market for insulin delivery devices is anticipated to experience significant growth in the coming years, predicting a rise to $26.3 billion by 2029 with a compound annual growth rate (CAGR) of 8.2%. This expected growth during the forecasted period can be credited to an increasing number of diabetic patients, higher healthcare spending on treating diabetes, the emergence of continuous glucose monitoring systems, increased patient awareness about the advantages of using automated insulin delivery systems, and a growing emphasis on healthcare. Key forecast period trends encompass advancements in insulin delivery device technology, the combination of digital technology with insulin delivery devices, the creation of artificial pancreas systems, progress in insulin administration technology, and bionic technology’s advancements.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

Who are the Major Competitors in the Insulin Delivery Devices Market Outlook?

Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices

What Is Fueling Growth in the Insulin Delivery Devices Market?

The insulin delivery devices market is predicted to expand due to the increasing incidence of diabetes. Diabetes, a chronic illness characterized by elevated blood sugar levels, can result from either insufficient production of insulin from the pancreas or the body’s failure to use insulin efficiently. The rise in diabetes is primarily attributed to factors like inactive lifestyles, unhealthy eating habits, and growing obesity rates worldwide. Insulin delivery devices are vital for managing diabetes as they allow the controlled and convenient administration of insulin, thereby averting complications and supporting health. For example, the Centers for Disease Control and Prevention, a US government agency, stated in December 2022 that the count of youngsters under 20 years with type 2 diabetes in the United States could surge by an estimated 700% by 2060, potentially affecting around 220,000 individuals. Simultaneously, diagnoses of type 1 diabetes among young people could increase by up to 65%. Hence, the rising prevalence of diabetes is fueling the insulin delivery devices market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp

Which Insulin Delivery Devices Market Segments Are Growing the Fastest?

The insulin delivery devices market covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

6) By Insulin Pumps: Traditional Insulin Pumps, Smart Insulin Pumps

7) By External Or Tethered Pumps: Traditional External Insulin Pumps, Wireless Tethered Pumps

8) By Patch Pumps: Patch Insulin Pumps, Integrated Patch Pumps

Which Industry Trends Are Shaping the Future of the Insulin Delivery Devices Market?

Leading corporations in the insulin delivery devices sector are prioritizing the invention of cutting-edge products, including insulin pumps, to offer either constant or customizable insulin delivery. Insulin pumps are medical devices that can be programmed to administer insulin either continuously or on an as-needed basis through a catheter inserted beneath the skin. For example, in May 2023, Beta Bionics, a medical technology company from the U.S., received approval from the U.S. Food and Drug Administration for its iLet ACE Pump and the iLet Dosing Decision Software. Tailored for individuals who are six years of age or older and have type 1 diabetes, the iLet Bionic Pancreas system amalgamates two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). Its functionality is reliant on an automated insulin dosing (AID) system propelled by an adaptive closed-loop algorithm, initially predicated solely on the user’s weight, thus eliminating the need for extra insulin dosing criteria. This system doesn’t require any manual setting adjustments in contrast with the conventional pump treatment, making it more user-friendly. Additionally, the iLet device unveils a feature that simplifies mealtime insulin dosing by dividing meals into small, medium, or large categories, with its algorithm adjusting and learning an individual’s insulin needs over time.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Which Countries Are Leading the Insulin Delivery Devices Market?

North America was the largest region in the insulin delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18642

This Report Delivers Insight On:

1. How big is the insulin delivery devices market, and how is it changing globally?

2. Who are the major companies in the insulin delivery devices market, and how are they performing?

3. What are the key opportunities and risks in the insulin delivery devices market right now?

4. Which products or customer segments are growing the most in the insulin delivery devices market?

5. What factors are helping or slowing down the growth of the insulin delivery devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model